+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

LAMEA Sclerotherapy Market By Agent (Detergents, Osmotic Agents and Chemical Irritants), By Type (Liquid Sclerotherapy, Ultrasound Sclerotherapy and Foam Sclerotherapy), By Country, Industry Analysis and Forecast, 2020 - 2026

  • ID: 5185530
  • Report
  • October 2020
  • Region: Middle East, Africa
  • 57 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • LGM Pharma, LLC
  • MTW-Endoskopie W. Haag KG
  • Tianyu Chang’an Group
  • MORE
The Latin America, Middle East and Africa Sclerotherapy Market is expected to witness market growth of 8.8% CAGR during the forecast period (2020-2026).

A foam with detergent sclerosants allows a more efficient sclerosant effect by increasing both dwell time and contact area while minimizing the admixture of sclerosant and blood. This increase in efficiency allows lower sclerosants doses. Ultrasound-guided foam sclerotherapy is an upcoming therapy which allows the doctor to monitor the effect of each injection while ensuring the safety of all adjacent structures and effective is more effective as compared to a liquid therapy.

The market has become highly competitive in nature. One of the key factors that is leading to the competitiveness among market players include rapid adoption of advanced technologies such as ultrasound-guided sclerotherapy, and foam therapy. Furthermore, a conspicuous number of these players are swiftly opting for collaborations and strategic expansions for growing their geographical presence and increasing sales volume in evolving and economically encouraging regions.

In the current scenario, more respected hospital is preferring to opt for minimally invasive surgical procedure including Sclerotherapy Treatment. Sclerosing agents that are used for the varicose veins treatment is segmented into detergents, chemical irritants, and hyperosmolar/ osmotic agents.

Based on Agent, the market is segmented into Detergents, Osmotic Agents and Chemical Irritants. Based on Type, the market is segmented into Liquid Sclerotherapy, Ultrasound Sclerotherapy and Foam Sclerotherapy. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Perrigo Company PLC (Omega Pharmaceuticals), Cook Medical, Inc. (Cook Group), Chemische Fabrik Kreussler & Co. GmbH, LGM Pharma, LLC, Troikaa Pharmaceuticals Limited, Tianyu Chang’an Group, Endo-Flex GmbH (Meditek Systems), Merz Pharma GmbH & Co. KGaA, and MTW-Endoskopie W. Haag KG.

Scope of the Study

Market Segmentation:

By Agent
  • Detergents
  • Osmotic Agents
  • Chemical Irritants
By Type
  • Liquid Sclerotherapy
  • Ultrasound Sclerotherapy
  • Foam Sclerotherapy
By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA
Companies Profiled
  • Boston Scientific Corporation
  • Perrigo Company PLC (Omega Pharmaceuticals)
  • Cook Medical, Inc. (Cook Group)
  • Chemische Fabrik Kreussler & Co. GmbH
  • LGM Pharma, LLC
  • Troikaa Pharmaceuticals Limited
  • Tianyu Chang’an Group
  • Endo-Flex GmbH (Meditek Systems)
  • Merz Pharma GmbH & Co. KGaA
  • MTW-Endoskopie W. Haag KG
Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • LGM Pharma, LLC
  • MTW-Endoskopie W. Haag KG
  • Tianyu Chang’an Group
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Sclerotherapy Market, by Agent
1.4.2 LAMEA Sclerotherapy Market, by Type
1.4.3 LAMEA Sclerotherapy Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. LAMEA Sclerotherapy Market by Agent
3.1 LAMEA Detergents Market by Country
3.2 LAMEA Osmotic Agents Market by Country
3.3 LAMEA Chemical Irritants Market by Country

Chapter 4. LAMEA Sclerotherapy Market by Type
4.1 LAMEA Liquid Sclerotherapy Market by Country
4.2 LAMEA Ultrasound Sclerotherapy Market by Country
4.3 LAMEA Other Type Market by Country

Chapter 5. LAMEA Sclerotherapy Market by Country
5.1 Brazil Sclerotherapy Market
5.1.1 Brazil Sclerotherapy Market by Agent
5.1.2 Brazil Sclerotherapy Market by Type
5.2 Argentina Sclerotherapy Market
5.2.1 Argentina Sclerotherapy Market by Agent
5.2.2 Argentina Sclerotherapy Market by Type
5.3 UAE Sclerotherapy Market
5.3.1 UAE Sclerotherapy Market by Agent
5.3.2 UAE Sclerotherapy Market by Type
5.4 Saudi Arabia Sclerotherapy Market
5.4.1 Saudi Arabia Sclerotherapy Market by Agent
5.4.2 Saudi Arabia Sclerotherapy Market by Type
5.5 South Africa Sclerotherapy Market
5.5.1 South Africa Sclerotherapy Market by Agent
5.5.2 South Africa Sclerotherapy Market by Type
5.6 Nigeria Sclerotherapy Market
5.6.1 Nigeria Sclerotherapy Market by Agent
5.6.2 Nigeria Sclerotherapy Market by Type
5.7 Rest of LAMEA Sclerotherapy Market
5.7.1 Rest of LAMEA Sclerotherapy Market by Agent
5.7.2 Rest of LAMEA Sclerotherapy Market by Type

Chapter 6. Company Profiles
6.1 Boston Scientific Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Perrigo Company PLC (Omega Pharmaceuticals)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Cook Medical, Inc. (Cook Group)
6.3.1 Company Overview
6.4 Chemische Fabrik Kreussler & Co. GmbH
6.4.1 Company Overview
6.5 LGM Pharma, LLC
6.5.1 Company Overview
6.6 Troikaa Pharmaceuticals Limited
6.6.1 Company Overview
6.7 Tianyu Chang’an Group
6.7.1 Company Overview
6.8 Endo-Flex GmbH (Meditek Systems)
6.8.1 Company Overview
6.9 Merz Pharma GmbH & Co. KGaA
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations, and Agreements:
6.10. MTW-Endoskopie W. Haag KG
6.10.1 Company Overview
Note: Product cover images may vary from those shown
  • Boston Scientific Corporation
  • Perrigo Company PLC (Omega Pharmaceuticals)
  • Cook Medical, Inc. (Cook Group)
  • Chemische Fabrik Kreussler & Co. GmbH
  • LGM Pharma, LLC
  • Troikaa Pharmaceuticals Limited
  • Tianyu Chang’an Group
  • Endo-Flex GmbH (Meditek Systems)
  • Merz Pharma GmbH & Co. KGaA
  • MTW-Endoskopie W. Haag KG
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll